News UK approves AZ inhaler with 'greener' propellant AstraZeneca has its first regulatory approval for an inhaler product using a propellant with a massively reduced global warming potential.
News AstraZeneca, Honeywell partner to address climate change wit... UK-based global pharma company AstraZeneca and US consumer products company Honeywell have announced a partnership to build a new "next generation" inhaler with a propellant that reduces Gl
News UK project addresses capacity issue in CGT manufacturing A UK consortium has been set up to tackle a major issue in the development of cell and gene therapies (CGT) – a lack of manufacturing capacity.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
